Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2022-09-22 Director's Dealing
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs)' and details the acquisition of ordinary shares by Directors (Ian Page, Paul Sandland, Tony Griffin). This content directly corresponds to reporting insider trades or director dealings. The presence of 'RNS Number' and the closing statement referencing RNS and the London Stock Exchange confirms it is a regulatory announcement. The specific definition matching this content is 'Director's Dealing (Code: DIRS)'.
2022-09-22 English
Dechra - 2022 AGM - Form of Proxy
Proxy Solicitation & Information Statement Classification · 100% confidence The document explicitly mentions the 'Annual General Meeting' (AGM) date and location, and contains a detailed 'Proxy Form' for shareholders to appoint a representative to vote on various resolutions (Ordinary and Special Business). This material is directly related to soliciting shareholder votes and providing information for the AGM. Therefore, it falls under the category of materials shared during or in preparation for the AGM, specifically the proxy solicitation materials.
2022-09-20 English
Dechra - Notice of 2022 Annual General Meeting
AGM Information Classification · 100% confidence The document is explicitly titled "ANNUAL GENERAL MEETING 2022 CHAIRMAN'S LETTER AND NOTICE OF ANNUAL GENERAL MEETING". It details the date, time, and location of the AGM, lists the resolutions to be voted upon (including receiving the Annual Report, approving the Remuneration Report, approving the dividend, and electing/re-electing Directors), and provides instructions for attending and voting. This content is the core material distributed to shareholders in connection with the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). Although it mentions the Annual Report and Accounts, the document itself is the Notice and Chairman's Letter for the meeting, not the full 10-K or the standalone Audit Report.
2022-09-20 English
Dechra - 2022 Annual Financial Report
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report and Accounts for the year ended 30 June 2022' for Dechra Pharmaceuticals PLC. It contains comprehensive sections including a Strategic Report, Governance, Financial Statements, and Independent Auditors' Report. It is a full-length annual report, not an announcement or a summary, and thus fits the definition of a 10-K (Annual Report). FY 2022
2022-09-20 English
Grant of award - Deferred Bonus Plan
Director's Dealing Classification · 100% confidence The document is titled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs)' and details the granting of share awards (options) to Directors (Ian Page, Paul Sandland, Tony Griffin) under a Deferred Bonus Plan. This explicitly concerns personal share transactions by company directors/executives. This aligns perfectly with the definition for Director's Dealing (DIRS). The presence of the RNS Number and the closing statement referencing RNS and the London Stock Exchange confirms it is a regulatory disclosure, but the specific content points directly to DIRS rather than the general RNS fallback.
2022-09-20 English
Posting of 2022 Annual Financial Report
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3077 characters) identified by an RNS Number (0246A) and dated September 20, 2022. The text explicitly states that the 'Annual Financial Report for the year ended 30 June 2022, Notice of Annual General Meeting and Proxy Form have today been mailed to shareholders' and that a copy has been submitted to the FCA document viewing facility. This structure—announcing the availability/mailing of official reports (Annual Financial Report, AGM Notice) rather than containing the full content of those reports—fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K, nor is it the AGM material itself, but the notice that they have been released.
2022-09-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.